Clinical trial
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
NCT00005975 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00005975 |
|---|---|
| Title | S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer |
| Official title | A Phase III Trial of Placebo Versus Megestrol Acetate 20 MG/Day Versus Megestrol Acetate 40 MG/Day as Treatment for Symptoms of Ovarian Failure in Women Treated for Breast Cancer: SWOG Study S9626 |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Hot Flashes |
| Intervention type | Drug |
| Interventions | Megestrol Acetate 20mg/day, Megestrol Acetate 40 mg/day, Megestrol Acetate Placebo 20 mg/day, Megestrol Acetate Placebo 40 mg/day |
| Enrollment | 288 |
| Start date | Apr 1, 1998 |
| Primary completion | Sep 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | Jun 28, 2004 |
| Last update posted | Nov 18, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: